Insulin is the recommended treatment of for both type-1 and type-2 diabetes patients. So far, there have been many advancements and several new analogues are now available, which offer benefits like high efficacy, safety, and better compliance.

Moreover, the clinical evidence suggests that the use of insulin can reduce comorbidities such as microvascular complications. In this regard, we would like to know your preferred insulin analogues and their potential advantages and limitations.